ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?

被引：0
|
作者：
Hsu, Jingmei [1 ]
Kumar, Anita J. [1 ]
Carroll, Martin P. [1 ]
Frey, Noelle V. [1 ]
Shah, Nirav N. [1 ,2 ]
Jianhua, Zhao [3 ]
Hexner, Elizabeth O. [1 ]
Loren, Alison W. [1 ]
Mangan, James K. [1 ]
Perl, Alexander E. [1 ]
Porter, David [1 ]
Morrissette, Jennifer [3 ]
Luger, Selina M. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] ASXL1 Mutations Predict for Resistance to Chemotherapy and Inferior Outcome in Younger Adult Patients with Acute Myeloid Leukemia (AML): A Study of the German-Austrian AMLSG
    Paschka, Peter
    Schlenk, Richard F.
    Herzig, Julia
    Aulitzky, Teresa
    Gaidzik, Verena I.
    Bullinger, Lars
    Habdank, Marianne
    Corbacioglu, Andrea
    Spaeth, Daniela
    Koehne, Claus-Henning
    Kuendgen, Andrea
    von Lilienfeld-Toal, Marie
    Held, Gerhard
    Horst, Heinz A.
    Goetze, Katharina
    Bentz, Martin
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2011, 118 (21) : 189 - 189
  • [42] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [43] Categorizing Molecular Mutations in MDS and AML
    Rose, Dominic
    Haferlach, Torsten
    Kern, Wolfgang
    Haferlach, Claudia
    BLOOD, 2015, 126 (23)
  • [44] Focusing on frequent ASXL1 mutations in myeloid neoplasms, and considering rarer ASXL2 and ASXL3 mutations
    Oak, Jean S.
    Ohgami, Robert S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 781 - 782
  • [45] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
    Van Ness, Michael
    Szankasi, Philippe
    Frizzell, Kimberly
    Shen, Wei
    Kelley, Todd W.
    LABORATORY INVESTIGATION, 2016, 96 : 381A - 381A
  • [46] Analysis of ASXL1 Mutations in a Large Series of Myeloid Malignancies
    Van Ness, Michael
    Szankasi, Philippe
    Frizzell, Kimberly
    Shen, Wei
    Kelley, Todd W.
    MODERN PATHOLOGY, 2016, 29 : 381A - 381A
  • [47] Molecular Pathways Mediating MDS/AML With Focus on AML1/RUNX1 Point Mutations
    Harada, Yuka
    Harada, Hironori
    JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 220 (01) : 16 - 20
  • [48] Mutations of ASXL1 and TET2 in aplastic anemia
    Huang, Jinbo
    Ge, Meili
    Lu, Shihong
    Shi, Jun
    Li, Xingxin
    Zhang, Jizhou
    Wang, Min
    Yu, Wei
    Shao, Yingqi
    Huang, Zhendong
    Zhang, Jing
    Nie, Neng
    Zheng, Yizhou
    HAEMATOLOGICA, 2015, 100 (05)
  • [49] Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
    Thol, Felicitas
    Friesen, Inna
    Damm, Frederik
    Yun, Haiyang
    Weissinger, Eva M.
    Krauter, Juergen
    Wagner, Katharina
    Chaturvedi, Anuhar
    Sharma, Amit
    Wichmann, Martin
    Goehring, Gudrun
    Schumann, Christiane
    Bug, Gesine
    Ottmann, Oliver
    Hofmann, Wolf-Karsten
    Schlegelberger, Brigitte
    Heuser, Michael
    Ganser, Arnold
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2499 - 2506
  • [50] RUNX1-mutant AML Has Similar Outcome to AML with Other Secondary-type Mutations
    Loneman, Derek
    Cantu, Miguel
    Weinberg, Olga
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1446 - S1448
12345